Literature DB >> 27105570

Ipsilateral Sinus Hypoplasia and Poor Leptomeningeal Collaterals as Midline Shift Predictors.

Ondrej Volny1, Petra Cimflova2, Robert Mikulik3.   

Abstract

BACKGROUND: We explore the role of dural sinus morphology, leptomeningeal collaterals, and clot localization in the development of malignant brain edema in acute ischemic stroke in anterior circulation.
METHODS: This is a single-center retrospective study of consecutive stroke patients with acute occlusion (middle cerebral artery M1 ± intracranial internal carotid artery) treated with intravenous thrombolysis (from November 2009 to November 2014). Admission computed tomography angiography data were evaluated for hypoplasia of dural sinuses, leptomeningeal collaterals, and clot location. Primary outcome was midline shift (<5 mm versus ≥5 mm) on follow-up computed tomography. Secondary outcomes were infarct volume and modified Rankin Scale score of 2 or lower at 90 days. Multivariate logistic regression was used.
RESULTS: Of 86 patients (49 females), 36 (42%) had poor collaterals, 26 (30%) had ipsilesional sinus hypoplasia, and 38 (44%) had proximal clots. A midline shift of 5 mm or higher was diagnosed in 14 patients (16%). Infarct volume was larger in the group with midline shift (median: 318 mL [interquartile range {IQR} = 260-350]) than in the group without midline shift (median: 44 mL [IQR = 28-60]) (P = .007). In multivariate analysis, poor leptomeningeal collaterals (odds ratio [OR] = .11, 95% confidence interval [CI] = .03-.44, P = .002 for good collaterals) and ipsilesional sinus hypoplasia (OR = 6.43, 95% CI = 1.5-46.1, P = .008) were independently associated with a midline shift of 5 mm or higher.
CONCLUSION: Patients with poor leptomeningeal collaterals and ipsilesional hypoplasia of dural sinuses are more likely to develop midline shift.
Copyright © 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; anterior circulation; dural sinuses; edema; leptomeningeal collaterals; midline shift

Mesh:

Year:  2016        PMID: 27105570     DOI: 10.1016/j.jstrokecerebrovasdis.2016.04.004

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Association of Reperfusion With Brain Edema in Patients With Acute Ischemic Stroke: A Secondary Analysis of the MR CLEAN Trial.

Authors:  W Taylor Kimberly; Bruna Garbugio Dutra; Anna M M Boers; Heitor C B R Alves; Olvert A Berkhemer; Lucie van den Berg; Kevin N Sheth; Yvo B W E M Roos; Aad van der Lugt; Ludo F M Beenen; Diederik W J Dippel; Wim H van Zwam; Robert J van Oostenbrugge; Hester F Lingsma; Henk Marquering; Charles B L M Majoie
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

2.  Filling Defect of Ipsilateral Transverse Sinus in Acute Large Artery Occlusion.

Authors:  Yi Chen; Sheng Zhang; Shenqiang Yan; Meixia Zhang; Ruiting Zhang; Feina Shi; David S Liebeskind; Mark Parsons; Min Lou
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

3.  Low-Dose Lithium Stabilizes Human Endothelial Barrier by Decreasing MLC Phosphorylation and Universally Augments Cholinergic Vasorelaxation Capacity in a Direct Manner.

Authors:  Bert Bosche; Marek Molcanyi; Soham Rej; Thorsten R Doeppner; Mark Obermann; Daniel J Müller; Anupam Das; Jürgen Hescheler; R Loch Macdonald; Thomas Noll; Frauke V Härtel
Journal:  Front Physiol       Date:  2016-12-06       Impact factor: 4.566

4.  The association between white matter changes and development of malignant middle cerebral artery infarction: A case-control study.

Authors:  Meng-Ni Wu; Pen-Tzu Fang; Chih-Hsien Hung; Chung-Yao Hsu; Ping-Song Chou; Yuan-Han Yang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

Review 5.  Cerebral edema after ischemic stroke: Pathophysiology and underlying mechanisms.

Authors:  Yuhang Gu; Chen Zhou; Zhe Piao; Honghua Yuan; Huimin Jiang; Huimin Wei; Yifan Zhou; Guangxian Nan; Xunming Ji
Journal:  Front Neurosci       Date:  2022-08-18       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.